サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1091389

世界のフッ素系医薬中間体市場：考察と予測 (2028年まで)

Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 108 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
世界のフッ素系医薬中間体市場：考察と予測 (2028年まで)
出版日: 2022年06月20日
発行: QYResearch
ページ情報: 英文 108 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、フッ素系医薬中間体 (Fluorinated Pharmaceutical Intermediates) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のフッ素系医薬中間体の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Inhalation Anesthetic Intermediates
    • Antiviral Drug Intermediates
    • Others
  • 市場：アプリケーション別
    • 世界のフッ素系医薬中間体の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Medicine Field
    • Health Field
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のフッ素系医薬中間体の市場展望 (2017-2028)
  • フッ素系医薬中間体の市場成長トレンド：地域別
    • フッ素系医薬中間体 市場規模：地域別: 2017 VS 2021 VS 2028
    • フッ素系医薬中間体の市場規模実績：地域別 (2017-2022)
    • フッ素系医薬中間体の市場規模予測：地域別 (2023-2028)
  • フッ素系医薬中間体 市場動向
    • フッ素系医薬中間体 業界動向
    • フッ素系医薬中間体 市場の促進要因
    • フッ素系医薬中間体 市場の課題
    • フッ素系医薬中間体 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界のフッ素系医薬中間体の上位企業：収益別
    • 世界のフッ素系医薬中間体の上位企業：収益別 (2017-2022)
    • 世界のフッ素系医薬中間体の収益シェア：企業別 (2017-2022)
  • 世界のフッ素系医薬中間体の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：フッ素系医薬中間体の収益
  • 世界のフッ素系医薬中間体 市場集中度
    • 世界のフッ素系医薬中間体 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： フッ素系医薬中間体の収益 2021
  • フッ素系医薬中間体の主要企業の本社および事業エリア
  • 主要企業 フッ素系医薬中間体の製品ソリューションおよびサービス
  • 市場参入時期： フッ素系医薬中間体 市場
  • M&A, 拡張計画

第4章 フッ素系医薬中間体 内訳データ：タイプ別

  • 世界のフッ素系医薬中間体の市場規模実績：タイプ別 (2017-2022)
  • 世界のフッ素系医薬中間体の市場規模予測：タイプ別 (2023-2028)

第5章 フッ素系医薬中間体 内訳データ：アプリケーション別

  • 世界のフッ素系医薬中間体の市場規模実績：アプリケーション別 (2017-2022)
  • 世界のフッ素系医薬中間体の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のフッ素系医薬中間体 市場規模 (2017-2028)
  • 北米のフッ素系医薬中間体 市場規模：タイプ別
    • 北米のフッ素系医薬中間体 市場規模：タイプ別 (2017-2022)
    • 北米のフッ素系医薬中間体 市場規模：タイプ別 (2023-2028)
    • 北米のフッ素系医薬中間体の市場シェア：タイプ別 (2017-2028)
  • 北米のフッ素系医薬中間体 市場規模：アプリケーション別
    • 北米のフッ素系医薬中間体 市場規模：アプリケーション別 (2017-2022)
    • 北米のフッ素系医薬中間体 市場規模：アプリケーション別 (2023-2028)
    • 北米のフッ素系医薬中間体の市場シェア：アプリケーション別 (2017-2028)
  • 北米のフッ素系医薬中間体 市場規模：国別
    • 北米のフッ素系医薬中間体 市場規模：国別 (2017-2022)
    • 北米のフッ素系医薬中間体 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のフッ素系医薬中間体 市場規模 (2017-2028)
  • 欧州のフッ素系医薬中間体 市場規模：タイプ別
    • 欧州のフッ素系医薬中間体 市場規模：タイプ別 (2017-2022)
    • 欧州のフッ素系医薬中間体 市場規模：タイプ別 (2023-2028)
    • 欧州のフッ素系医薬中間体の市場シェア：タイプ別 (2017-2028)
  • 欧州のフッ素系医薬中間体 市場規模：アプリケーション別
    • 欧州のフッ素系医薬中間体 市場規模：アプリケーション別 (2017-2022)
    • 欧州のフッ素系医薬中間体 市場規模：アプリケーション別 (2023-2028)
    • 欧州のフッ素系医薬中間体の市場シェア：アプリケーション別 (2017-2028)
  • 欧州のフッ素系医薬中間体 市場規模：国別
    • 欧州のフッ素系医薬中間体 市場規模：国別 (2017-2022)
    • 欧州のフッ素系医薬中間体 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 フッ素系医薬中間体 市場規模 (2017-2028)
  • アジア太平洋地域 フッ素系医薬中間体 市場規模：タイプ別
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 フッ素系医薬中間体の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 フッ素系医薬中間体 市場規模：アプリケーション別
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 フッ素系医薬中間体の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 フッ素系医薬中間体 市場規模：地域別
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 フッ素系医薬中間体 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのフッ素系医薬中間体 市場規模 (2017-2028)
  • ラテンアメリカのフッ素系医薬中間体 市場規模：タイプ別
    • ラテンアメリカのフッ素系医薬中間体 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカのフッ素系医薬中間体 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカのフッ素系医薬中間体の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカのフッ素系医薬中間体 市場規模：アプリケーション別
    • ラテンアメリカのフッ素系医薬中間体 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカのフッ素系医薬中間体 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカのフッ素系医薬中間体の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカのフッ素系医薬中間体 市場規模：国別
    • ラテンアメリカのフッ素系医薬中間体 市場規模：国別 (2017-2022)
    • ラテンアメリカのフッ素系医薬中間体 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのフッ素系医薬中間体 市場規模 (2017-2028)
  • 中東・アフリカのフッ素系医薬中間体 市場規模：タイプ別
    • 中東・アフリカのフッ素系医薬中間体 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカのフッ素系医薬中間体 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカのフッ素系医薬中間体の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカのフッ素系医薬中間体 市場規模：アプリケーション別
    • 中東・アフリカのフッ素系医薬中間体 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカのフッ素系医薬中間体 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカのフッ素系医薬中間体の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカのフッ素系医薬中間体 市場規模：国別
    • 中東・アフリカのフッ素系医薬中間体 市場規模：国別 (2017-2022)
    • 中東・アフリカのフッ素系医薬中間体 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Bayer
  • DuPont
  • BASF SE
  • Zhejiang Yongtai Technology
  • Jinzhou Hengtong Fluorine Chemicals
  • Fuxin Custchem Fine Chemical
  • Shenzhen Capchem Technology
  • NORINCO GROUP
  • Zhejiang Zhongxin Fluoride Materials
  • Jiangsu Feiyu Pharmaceutical Technology
  • JIANG LIN JIANG CHEMICAL
  • Lianyungang Cca Chemical
  • Shaoxing Xingxin New Material
  • Jiangsu Yongchuang Pharmaceutical Technology

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Inhalation Anesthetic Intermediates
  • Table 3. Key Players of Antiviral Drug Intermediates
  • Table 4. Key Players of Others
  • Table 5. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2017-2022)
  • Table 9. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2023-2028)
  • Table 11. Fluorinated Pharmaceutical Intermediates Market Trends
  • Table 12. Fluorinated Pharmaceutical Intermediates Market Drivers
  • Table 13. Fluorinated Pharmaceutical Intermediates Market Challenges
  • Table 14. Fluorinated Pharmaceutical Intermediates Market Restraints
  • Table 15. Global Fluorinated Pharmaceutical Intermediates Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Players (2017-2022)
  • Table 17. Global Top Fluorinated Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2021)
  • Table 18. Ranking of Global Top Fluorinated Pharmaceutical Intermediates Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
  • Table 22. Date of Enter into Fluorinated Pharmaceutical Intermediates Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2017-2022)
  • Table 26. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2023-2028)
  • Table 28. Global Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Application (2017-2022)
  • Table 30. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Application (2023-2028)
  • Table 32. North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Bayer Company Details
  • Table 63. Bayer Business Overview
  • Table 64. Bayer Fluorinated Pharmaceutical Intermediates Product
  • Table 65. Bayer Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 66. Bayer Recent Developments
  • Table 67. DuPont Company Details
  • Table 68. DuPont Business Overview
  • Table 69. DuPont Fluorinated Pharmaceutical Intermediates Product
  • Table 70. DuPont Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 71. DuPont Recent Developments
  • Table 72. BASF SE Company Details
  • Table 73. BASF SE Business Overview
  • Table 74. BASF SE Fluorinated Pharmaceutical Intermediates Product
  • Table 75. BASF SE Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 76. BASF SE Recent Developments
  • Table 77. Zhejiang Yongtai Technology Company Details
  • Table 78. Zhejiang Yongtai Technology Business Overview
  • Table 79. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product
  • Table 80. Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 81. Zhejiang Yongtai Technology Recent Developments
  • Table 82. Jinzhou Hengtong Fluorine Chemicals Company Details
  • Table 83. Jinzhou Hengtong Fluorine Chemicals Business Overview
  • Table 84. Jinzhou Hengtong Fluorine Chemicals Fluorinated Pharmaceutical Intermediates Product
  • Table 85. Jinzhou Hengtong Fluorine Chemicals Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 86. Jinzhou Hengtong Fluorine Chemicals Recent Developments
  • Table 87. Fuxin Custchem Fine Chemical Company Details
  • Table 88. Fuxin Custchem Fine Chemical Business Overview
  • Table 89. Fuxin Custchem Fine Chemical Fluorinated Pharmaceutical Intermediates Product
  • Table 90. Fuxin Custchem Fine Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 91. Fuxin Custchem Fine Chemical Recent Developments
  • Table 92. Shenzhen Capchem Technology Company Details
  • Table 93. Shenzhen Capchem Technology Business Overview
  • Table 94. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product
  • Table 95. Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 96. Shenzhen Capchem Technology Recent Developments
  • Table 97. NORINCO GROUP Company Details
  • Table 98. NORINCO GROUP Business Overview
  • Table 99. NORINCO GROUP Fluorinated Pharmaceutical Intermediates Product
  • Table 100. NORINCO GROUP Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 101. NORINCO GROUP Recent Developments
  • Table 102. Zhejiang Zhongxin Fluoride Materials Company Details
  • Table 103. Zhejiang Zhongxin Fluoride Materials Business Overview
  • Table 104. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product
  • Table 105. Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 106. Zhejiang Zhongxin Fluoride Materials Recent Developments
  • Table 107. Jiangsu Feiyu Pharmaceutical Technology Company Details
  • Table 108. Jiangsu Feiyu Pharmaceutical Technology Business Overview
  • Table 109. Jiangsu Feiyu Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Product
  • Table 110. Jiangsu Feiyu Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 111. Jiangsu Feiyu Pharmaceutical Technology Recent Developments
  • Table 112. JIANG LIN JIANG CHEMICAL Company Details
  • Table 113. JIANG LIN JIANG CHEMICAL Business Overview
  • Table 114. JIANG LIN JIANG CHEMICAL Fluorinated Pharmaceutical Intermediates Product
  • Table 115. JIANG LIN JIANG CHEMICAL Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 116. JIANG LIN JIANG CHEMICAL Recent Developments
  • Table 117. Lianyungang Cca Chemical Company Details
  • Table 118. Lianyungang Cca Chemical Business Overview
  • Table 119. Lianyungang Cca Chemical Fluorinated Pharmaceutical Intermediates Product
  • Table 120. Lianyungang Cca Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 121. Lianyungang Cca Chemical Recent Developments
  • Table 122. Shaoxing Xingxin New Material Company Details
  • Table 123. Shaoxing Xingxin New Material Business Overview
  • Table 124. Shaoxing Xingxin New Material Fluorinated Pharmaceutical Intermediates Product
  • Table 125. Shaoxing Xingxin New Material Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 126. Shaoxing Xingxin New Material Recent Developments
  • Table 127. Jiangsu Yongchuang Pharmaceutical Technology Company Details
  • Table 128. Jiangsu Yongchuang Pharmaceutical Technology Business Overview
  • Table 129. Jiangsu Yongchuang Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Product
  • Table 130. Jiangsu Yongchuang Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
  • Table 131. Jiangsu Yongchuang Pharmaceutical Technology Recent Developments
  • Table 132. Research Programs/Design for This Report
  • Table 133. Key Data Information from Secondary Sources
  • Table 134. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Fluorinated Pharmaceutical Intermediates Market Share by Type: 2021 VS 2028
  • Figure 2. Inhalation Anesthetic Intermediates Features
  • Figure 3. Antiviral Drug Intermediates Features
  • Figure 4. Others Features
  • Figure 5. Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2021 VS 2028
  • Figure 6. Medicine Field Case Studies
  • Figure 7. Health Field Case Studies
  • Figure 8. Fluorinated Pharmaceutical Intermediates Report Years Considered
  • Figure 9. Global Fluorinated Pharmaceutical Intermediates Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Fluorinated Pharmaceutical Intermediates Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Fluorinated Pharmaceutical Intermediates Market Share by Region: 2021 VS 2028
  • Figure 12. Global Fluorinated Pharmaceutical Intermediates Market Share by Players in 2021
  • Figure 13. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue in 2021
  • Figure 15. North America Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
  • Figure 19. United States Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
  • Figure 25. Germany Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Share by Region (2017-2028)
  • Figure 35. China Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 41. Latin America Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Bayer Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 55. DuPont Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 56. BASF SE Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 57. Zhejiang Yongtai Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 58. Jinzhou Hengtong Fluorine Chemicals Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 59. Fuxin Custchem Fine Chemical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 60. Shenzhen Capchem Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 61. NORINCO GROUP Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 62. Zhejiang Zhongxin Fluoride Materials Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 63. Jiangsu Feiyu Pharmaceutical Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 64. JIANG LIN JIANG CHEMICAL Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 65. Lianyungang Cca Chemical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 66. Shaoxing Xingxin New Material Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 67. Jiangsu Yongchuang Pharmaceutical Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
目次

This research report focuses on the Fluorinated Pharmaceutical Intermediates Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Inhalation Anesthetic Intermediates
    • 1.2.3 Antiviral Drug Intermediates
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Medicine Field
    • 1.3.3 Health Field
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2017-2028)
  • 2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region
    • 2.2.1 Fluorinated Pharmaceutical Intermediates Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2017-2022)
    • 2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2023-2028)
  • 2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics
    • 2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends
    • 2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers
    • 2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges
    • 2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
    • 3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2017-2022)
    • 3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2017-2022)
  • 3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue
  • 3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio
    • 3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2021
  • 3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served
  • 3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
  • 3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type

  • 4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2017-2022)
  • 4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2023-2028)

5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application

  • 5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2017-2022)
  • 5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
  • 6.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Type
    • 6.2.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
    • 6.2.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
    • 6.2.3 North America Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
  • 6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Application
    • 6.3.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
    • 6.3.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
    • 6.3.3 North America Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
  • 6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country
    • 6.4.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
    • 6.4.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
  • 7.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type
    • 7.2.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
    • 7.2.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
    • 7.2.3 Europe Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
  • 7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application
    • 7.3.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
    • 7.3.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
    • 7.3.3 Europe Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
  • 7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country
    • 7.4.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
    • 7.4.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
  • 8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type
    • 8.2.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application
    • 8.3.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region
    • 8.4.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
  • 9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type
    • 9.2.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
    • 9.2.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
    • 9.2.3 Latin America Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
  • 9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application
    • 9.3.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
    • 9.3.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
    • 9.3.3 Latin America Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
  • 9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country
    • 9.4.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
    • 9.4.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
  • 10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type
    • 10.2.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application
    • 10.3.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country
    • 10.4.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Company Details
    • 11.1.2 Bayer Business Overview
    • 11.1.3 Bayer Fluorinated Pharmaceutical Intermediates Introduction
    • 11.1.4 Bayer Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.1.5 Bayer Recent Developments
  • 11.2 DuPont
    • 11.2.1 DuPont Company Details
    • 11.2.2 DuPont Business Overview
    • 11.2.3 DuPont Fluorinated Pharmaceutical Intermediates Introduction
    • 11.2.4 DuPont Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.2.5 DuPont Recent Developments
  • 11.3 BASF SE
    • 11.3.1 BASF SE Company Details
    • 11.3.2 BASF SE Business Overview
    • 11.3.3 BASF SE Fluorinated Pharmaceutical Intermediates Introduction
    • 11.3.4 BASF SE Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.3.5 BASF SE Recent Developments
  • 11.4 Zhejiang Yongtai Technology
    • 11.4.1 Zhejiang Yongtai Technology Company Details
    • 11.4.2 Zhejiang Yongtai Technology Business Overview
    • 11.4.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction
    • 11.4.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.4.5 Zhejiang Yongtai Technology Recent Developments
  • 11.5 Jinzhou Hengtong Fluorine Chemicals
    • 11.5.1 Jinzhou Hengtong Fluorine Chemicals Company Details
    • 11.5.2 Jinzhou Hengtong Fluorine Chemicals Business Overview
    • 11.5.3 Jinzhou Hengtong Fluorine Chemicals Fluorinated Pharmaceutical Intermediates Introduction
    • 11.5.4 Jinzhou Hengtong Fluorine Chemicals Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.5.5 Jinzhou Hengtong Fluorine Chemicals Recent Developments
  • 11.6 Fuxin Custchem Fine Chemical
    • 11.6.1 Fuxin Custchem Fine Chemical Company Details
    • 11.6.2 Fuxin Custchem Fine Chemical Business Overview
    • 11.6.3 Fuxin Custchem Fine Chemical Fluorinated Pharmaceutical Intermediates Introduction
    • 11.6.4 Fuxin Custchem Fine Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.6.5 Fuxin Custchem Fine Chemical Recent Developments
  • 11.7 Shenzhen Capchem Technology
    • 11.7.1 Shenzhen Capchem Technology Company Details
    • 11.7.2 Shenzhen Capchem Technology Business Overview
    • 11.7.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction
    • 11.7.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.7.5 Shenzhen Capchem Technology Recent Developments
  • 11.8 NORINCO GROUP
    • 11.8.1 NORINCO GROUP Company Details
    • 11.8.2 NORINCO GROUP Business Overview
    • 11.8.3 NORINCO GROUP Fluorinated Pharmaceutical Intermediates Introduction
    • 11.8.4 NORINCO GROUP Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.8.5 NORINCO GROUP Recent Developments
  • 11.9 Zhejiang Zhongxin Fluoride Materials
    • 11.9.1 Zhejiang Zhongxin Fluoride Materials Company Details
    • 11.9.2 Zhejiang Zhongxin Fluoride Materials Business Overview
    • 11.9.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction
    • 11.9.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.9.5 Zhejiang Zhongxin Fluoride Materials Recent Developments
  • 11.10 Jiangsu Feiyu Pharmaceutical Technology
    • 11.10.1 Jiangsu Feiyu Pharmaceutical Technology Company Details
    • 11.10.2 Jiangsu Feiyu Pharmaceutical Technology Business Overview
    • 11.10.3 Jiangsu Feiyu Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Introduction
    • 11.10.4 Jiangsu Feiyu Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.10.5 Jiangsu Feiyu Pharmaceutical Technology Recent Developments
  • 11.11 JIANG LIN JIANG CHEMICAL
    • 11.11.1 JIANG LIN JIANG CHEMICAL Company Details
    • 11.11.2 JIANG LIN JIANG CHEMICAL Business Overview
    • 11.11.3 JIANG LIN JIANG CHEMICAL Fluorinated Pharmaceutical Intermediates Introduction
    • 11.11.4 JIANG LIN JIANG CHEMICAL Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.11.5 JIANG LIN JIANG CHEMICAL Recent Developments
  • 11.12 Lianyungang Cca Chemical
    • 11.12.1 Lianyungang Cca Chemical Company Details
    • 11.12.2 Lianyungang Cca Chemical Business Overview
    • 11.12.3 Lianyungang Cca Chemical Fluorinated Pharmaceutical Intermediates Introduction
    • 11.12.4 Lianyungang Cca Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.12.5 Lianyungang Cca Chemical Recent Developments
  • 11.13 Shaoxing Xingxin New Material
    • 11.13.1 Shaoxing Xingxin New Material Company Details
    • 11.13.2 Shaoxing Xingxin New Material Business Overview
    • 11.13.3 Shaoxing Xingxin New Material Fluorinated Pharmaceutical Intermediates Introduction
    • 11.13.4 Shaoxing Xingxin New Material Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.13.5 Shaoxing Xingxin New Material Recent Developments
  • 11.14 Jiangsu Yongchuang Pharmaceutical Technology
    • 11.14.1 Jiangsu Yongchuang Pharmaceutical Technology Company Details
    • 11.14.2 Jiangsu Yongchuang Pharmaceutical Technology Business Overview
    • 11.14.3 Jiangsu Yongchuang Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Introduction
    • 11.14.4 Jiangsu Yongchuang Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    • 11.14.5 Jiangsu Yongchuang Pharmaceutical Technology Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer